{"title":"乳腺疾病和乳腺癌的生物学、生化和形态学标记。","authors":"A J Leathem","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The present most useful markers for breast appear to be: a. Actin, myosin and cytokeratins for distinguishing benign (mixed) from malignant (single cell) proliferations. b. Psychological assessment for prediction of long term cancer survival (Pettingale, 1985). c. Helix pomatia lectin binding for distinguishing cancers that have metastasized from those that have not. This is so far limited to 3 independent retrospective studies (Leathem, 1987; Fenlon, 1987; Fukutomi, 1989) and now needs prospective confirmation.</p>","PeriodicalId":7002,"journal":{"name":"Acta histochemica. Supplementband","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biological, biochemical and morphological markers of breast disorders and of breast cancer.\",\"authors\":\"A J Leathem\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The present most useful markers for breast appear to be: a. Actin, myosin and cytokeratins for distinguishing benign (mixed) from malignant (single cell) proliferations. b. Psychological assessment for prediction of long term cancer survival (Pettingale, 1985). c. Helix pomatia lectin binding for distinguishing cancers that have metastasized from those that have not. This is so far limited to 3 independent retrospective studies (Leathem, 1987; Fenlon, 1987; Fukutomi, 1989) and now needs prospective confirmation.</p>\",\"PeriodicalId\":7002,\"journal\":{\"name\":\"Acta histochemica. Supplementband\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta histochemica. Supplementband\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta histochemica. Supplementband","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Biological, biochemical and morphological markers of breast disorders and of breast cancer.
The present most useful markers for breast appear to be: a. Actin, myosin and cytokeratins for distinguishing benign (mixed) from malignant (single cell) proliferations. b. Psychological assessment for prediction of long term cancer survival (Pettingale, 1985). c. Helix pomatia lectin binding for distinguishing cancers that have metastasized from those that have not. This is so far limited to 3 independent retrospective studies (Leathem, 1987; Fenlon, 1987; Fukutomi, 1989) and now needs prospective confirmation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
